Deep, targeted next-technology sequencing has discovered that subclonal mutations (i.e., All those current in only a fraction of tumor cells) can be detected for all driver genes and therefore are related to quick disorder progression and poor outcome.eleven–thirteen This is especially applicable for TP53The medical training course of CLL is rath